Prevention of doxorubicin-induced congestive heart failure by continuous intravenous infusion in multiple myeloma; a case report and review of the literature.
Doxorubicin (Adriamycin) is an effective antitumour drug. Its major side-effect, cardiotoxicity, is markedly reduced by giving it as a continuous infusion, as illustrated by a case history and review of the literature.
Lieverse
R J
RJ
Free University Hospital, Amsterdam, The Netherlands.
Ossenkoppele
G J
GJ
D000368:Aged; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006333:Heart Failure / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*
D004317:Doxorubicin